FTC Sues Hims & Hers Over Health Data and Billing Practices

Shares of Hims & Hers tumbled roughly 10% after the Federal Trade Commission announced a lawsuit against the telehealth company, targeting what regulators described as unauthorized sharing of sensitive health data with major social media platforms and deceptive billing conduct. The complaint names Meta and Snap as recipients of consumer health information — a pairing that underscores growing regulatory anxiety about the intersection of digital advertising infrastructure and intimate medical data.

The allegations carry significant weight because telehealth companies occupy a uniquely exposed position in the data economy. Unlike traditional healthcare providers bound by HIPAA's strictest provisions, digital health platforms have at times operated in regulatory gray zones, collecting granular behavioral and health information while simultaneously relying on ad-tech pipelines to drive customer acquisition. If the FTC's claims hold up, they would represent a serious indictment of a business model that many consumer-facing health startups have quietly adopted.

The billing and subscription cancellation allegations add a second front to the agency's case. Regulators have increasingly scrutinized so-called "dark patterns" — design choices that make it easy to sign up for services but deliberately difficult to cancel them. For a company like Hims & Hers, which built its brand on frictionless access to prescriptions and wellness products, accusations of friction on the exit side could meaningfully erode consumer trust at a pivotal moment for the telehealth sector.

The market reaction — a swift double-digit percentage decline — reflects investor sensitivity to regulatory risk in a sector that has already faced scrutiny over prescription practices and marketing claims. The lawsuit arrives as the FTC under its current leadership has signaled an intent to aggressively police data privacy across consumer-facing digital industries, making Hims & Hers a potentially high-profile test case for how far that authority extends into health commerce.

Continue reading at US Top News and Analysis.